Horizon Therapeutics Public Ltd Co

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Report date

9/30/2023

Quarter

2023 Q3

Filed

11/14/2023

Shares

347,967

Value ($000)

40,256

Weight

0.1%

2019 Q4 - 2023 Q3 (16 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q3	11/14/2023	40,256	0.1%	347,967	9/30/2023
2023 Q2	8/11/2023	34,557	0.1%	335,995	6/30/2023
2023 Q1	5/16/2023	38,696	0.1%	354,554	3/31/2023
2022 Q4	2/14/2023	79,815	0.2%	701,365	12/31/2022
2022 Q3	11/14/2022	27,100	0.1%	437,879	9/30/2022
2022 Q2	8/15/2022	35,611	0.1%	446,471	6/30/2022
2022 Q1	5/16/2022	18,030	0.0%	171,374	3/31/2022
2021 Q4	2/14/2022	20,374	0.0%	189,067	12/31/2021
2021 Q3	11/15/2021	21,254	0.0%	194,036	9/30/2021
2021 Q2	8/11/2021	10,825	0.0%	115,605	6/30/2021
2021 Q1	5/17/2021	38,049	0.0%	413,401	3/31/2021
2020 Q4	2/16/2021	26,448	0.0%	361,556	12/31/2020
2020 Q3	11/16/2020	6,971	0.0%	89,745	9/30/2020
2020 Q2	8/14/2020	807	0.0%	14,527	6/30/2020
2020 Q1	5/15/2020	975	0.0%	32,903	3/31/2020
2019 Q4	2/14/2020	731	0.0%	20,192	12/31/2019